Compare WEAV & CGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WEAV | CGC |
|---|---|---|
| Founded | 2011 | N/A |
| Country | United States | Canada |
| Employees | N/A | 1128 |
| Industry | EDP Services | Pharmaceuticals and Biotechnology |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 413.7M | 389.2M |
| IPO Year | 2021 | 2023 |
| Metric | WEAV | CGC |
|---|---|---|
| Price | $7.33 | $0.94 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 5 | 1 |
| Target Price | ★ $11.00 | N/A |
| AVG Volume (30 Days) | ★ 3.1M | 2.9M |
| Earning Date | 04-30-2026 | 05-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 7.50 | ★ 84.17 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $239,024,000.00 | $12,759,000.00 |
| Revenue This Year | $17.20 | $8.27 |
| Revenue Next Year | $13.74 | $15.68 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 16.99 | N/A |
| 52 Week Low | $4.24 | $0.84 |
| 52 Week High | $7.98 | $2.38 |
| Indicator | WEAV | CGC |
|---|---|---|
| Relative Strength Index (RSI) | 63.04 | 38.82 |
| Support Level | $6.94 | $0.91 |
| Resistance Level | $7.33 | $1.15 |
| Average True Range (ATR) | 0.02 | 0.03 |
| MACD | -0.02 | -0.01 |
| Stochastic Oscillator | 56.43 | 9.41 |
Weave Communications Inc is a customer experience and payments software platform tailored for SMB healthcare businesses that revolutionizes patient interaction from initial contact to billing. It integrates diverse workflows into a unified solution, minimizing manual tasks and maximizing patient engagement. Weave democratizes enterprise-level communication tools, simplifying them for SMBs in a singular platform. Offering varied communication channels, appointment scheduling, payment processing, and more enhances practitioner-patient relationships and optimizes practice operations. The company has a singular operating segment and generates revenue mainly from subscriptions.
Canopy Growth Corp is a cannabis company that produces, distributes, and sells a diverse range of cannabis and cannabis-related products for adult-use and medical purposes under a portfolio of distinct brands in Canada. The Company supplies cannabis products in Canada, Europe, and Australia. It is focused on the medical and adult-use cannabis markets in Canada, offering a broad portfolio of brands and formats for medical cannabis patients and adult-use consumers. The Company operates through two reportable segments: Cannabis, which generates maximum revenue and includes the production, distribution, and sale of cannabis and cannabis-related products, and Storz & Bickel, which includes the production, distribution, and sale of vaporizers and accessories.